Establishment of the first lung cancer model (targeting Ras and/or PTEN knockdown) in Drosophila. Subsequent drug screening using this model revealed the potential effect of Trametinib and Fluvastatin for lung cancer. This evidence concerns the gene PTEN and lung cancer.